1. Home
  2. CCCC vs AUDC Comparison

CCCC vs AUDC Comparison

Compare CCCC & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.11

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Logo AudioCodes Ltd.

AUDC

AudioCodes Ltd.

HOLD

Current Price

$8.95

Market Cap

267.0M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCCC
AUDC
Founded
2015
1992
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
240.3M
267.0M
IPO Year
2020
1999

Fundamental Metrics

Financial Performance
Metric
CCCC
AUDC
Price
$2.11
$8.95
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$7.25
$11.67
AVG Volume (30 Days)
2.0M
95.7K
Earning Date
11-06-2025
02-03-2026
Dividend Yield
N/A
4.48%
EPS Growth
N/A
15.76
EPS
N/A
0.46
Revenue
$30,108,000.00
$244,553,000.00
Revenue This Year
N/A
$2.98
Revenue Next Year
N/A
$3.40
P/E Ratio
N/A
$19.21
Revenue Growth
N/A
0.15
52 Week Low
$1.09
$8.01
52 Week High
$4.26
$12.72

Technical Indicators

Market Signals
Indicator
CCCC
AUDC
Relative Strength Index (RSI) 39.90 48.05
Support Level $1.93 $8.79
Resistance Level $2.13 $9.20
Average True Range (ATR) 0.14 0.24
MACD -0.04 0.01
Stochastic Oscillator 21.08 33.37

Price Performance

Historical Comparison
CCCC
AUDC

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About AUDC AudioCodes Ltd.

AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.

Share on Social Networks: